ClinicalTrials.gg
RecruitingNCT04888104Updated Feb 17, 2026

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

An observational study in Adult Spinal Deformity, Scoliosis and Kyphosis, sponsored by International Spine Study Group Foundation. Recruiting at 9 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by International Spine Study Group Foundation · Observational

From the registry’s dates

  • Started Jul 2021; still recruiting 5 years 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
225
Ages
18 Years and older
Sex
All
01

Study summary

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Read the detailed description

Specific Aims:

  • Evaluate the safety and performance of posterior spinal fusion constructs supplemented with posterior spinolaminar fixation using the VersaTie System compared to posterior fixation constructs without VersaTie System supplementation in adult patients undergoing long posterior spinal fusion by evaluating intraoperative and postoperative complications, clinical and radiographic outcomes, patient-reported outcomes (PROs) and need for revision surgery.
  • Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery.
  • Develop and validate a standardized, universal complications classification system for spine surgery
  • Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for adult spinal deformity surgery
  • Assess impact of opioid use and pain management on patient cost, complications and outcomes
  • Evaluate optimal opioid and analgesic usage and protocols for standard work development
  • Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including modified Oswestry Disability Index (mODI), Scoliosis Research Society Questionnaire 22r (SRS-22r), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS) and compare the results of these legacy PROMs to outcomes scores as measured by the NIH Patient Reported Outcomes Measurement Information System (PROMIS) - PROMIS Anxiety, Depression, Pain Interference, Physical Function, and Social Satisfaction. Secondary aims for PROM research for this study include

    1. Validation of the PROMIS tool for ASD
    2. Establish a core set of PROMs for best practice guidelines for ASD
    3. Evaluate patient reported outcome variance for ASD according to SRS-Schwab spine deformity type including variance in baseline PROM domains impacted and variance in improvement in PROM domains
    4. Evaluate ASD outcomes compared to population norms and investigate/develop appropriate measures of clinically significant improvement
  • Evaluate clinical outcomes stratifying by patient chronological and physiological age
  • Evaluate measures to quantify patient physiological age including patient frailty for ASD and validate a frailty measurement system for ASD
  • Evaluate the role of functional tests in patient's baseline frailty assessment including hand manometer and Edmonton Frail Scale. See appendix, pages 17 \& 18 for details.
  • Evaluate the contribution of patient frailty to patient outcomes, complications, cost of care, disability, and complications
  • Evaluate if patient frailty is a static measure or if frailty is a dynamic measure that can be improved through "pre-habilitation" and if the according associations with reductions in frailty correlate with reductions of cost, complications, and improvement in outcomes
  • Evaluate cost variance for ASD surgery according to patient, institution, and geographical region and evaluate the cost effectiveness of surgical intervention for ASD
  • Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients and establish best practice guidelines for assessing MH for ASD patients
  • Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for ASD surgery
  • Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for ASD surgery and risk factors for routine (home) discharge vs. skilled nursing facility (SNF)/rehabilitation facility
  • Broaden the evaluation of the surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications
  • Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for surgical treatment of ASD
  • Develop predictive analytic algorithms to risk stratify for best/worst outcomes, complications, sentinel events, and economic loss for ASD surgery
  • Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.
02

Conditions studied

  • Adult Spinal Deformity
  • Scoliosis
  • Kyphosis

Browse trials for

Keywords

  • Scoliosis
  • Kyphosis
  • Sagittal Imbalance
03

In context

Scoliosis

660 studies on the registry are indexed under Scoliosis; 186 are open to participants now.

This study's planned enrollment of 225 is above the median of 84 across 256 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

International Spine Study Group Foundation is the lead sponsor of 7 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Multicenter, prospective, observational, study evaluating the safety and performance of the VersaTie System by comparing adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. >18 years of age at the time of treatment
  2. EOS full body or standing 36" AP \& Lateral images of entire spine
  3. Posterior spine fusion with pedicle screw fixation construct of 5 or more levels
  4. Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system
  5. Upper instrumented vertebra (UIV) terminating at a newly instrumented level
  6. Lowest instrumented vertebra (LIV) sacrum/pelvis
  7. Surgery scheduled to take place in the next 6 months

Exclusion criteria

Exclusion Criteria:

  1. Active spine tumor or infection
  2. Deformity due to acute trauma
  3. Prisoners
  4. Women who are pregnant
  5. Patient is unwilling or unable to complete questionnaires
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
225 participants (estimated)
Patient registry
No

Groups and cohorts

  • VersaTie

    Procedure: Index or revision spine surgery for complex adult spinal deformity

Interventions

  • ProcedureIndex or revision spine surgery for complex adult spinal deformity

    Adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System.

    Also known as: VersaTie System

06

What researchers measure

Primary outcomes

  1. Scoliosis Research Society (SRS) 22r

    Scoliosis specific patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  2. Oswestry

    Spine specific patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  3. Veterans RAND 12 Item Health Survey (VR-12)

    Patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  4. Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety

    Patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  5. Patient-Reported Outcome Measurement Information System (PROMIS) - Depression

    Patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  6. Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference

    Patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  7. Patient-Reported Outcome Measurement Information System (PROMIS) - Physical Function

    Patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  8. Patient-Reported Outcome Measurement Information System (PROMIS) - Social Satisfaction

    Patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  9. Patient-Reported Outcome Measurement Information System (PROMIS) - Social Role

    Patient reported outcome

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  10. Visual Analog Scale - Back Pain

    Self-reported back pain on scale of 0 (No pain) to 10 (severe pain)

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  11. Visual Analog Scale - Leg Pain

    Self-reported leg pain on scale of 0 (No pain) to 10 (severe pain)

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

Secondary outcomes

  1. Edmonton Frail Scale

    Evaluate frailty on scale of 0 to 17 where higher scores mean more frail

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  2. Canadian Study of Health and Aging (CSHA)

    Frailty scale of 1 to 9; higher scores mean more frail

    Time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  3. Adverse Events

    Occurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study \[Time Frame: 3 months and 1, 2, 5 \& 10 year post treatment\]

    Time frame: 3 months and 1, 2, 5 & 10 year post treatment

07

Study locations

7 of 9 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04888104
Lead sponsor
International Spine Study Group Foundation
Collaborators
NuVasive
Responsible party
Sponsor
First posted
May 17, 2021
Start date
Jul 9, 2021
Primary completion
Dec 31, 2031 (estimated)
Completion
Dec 31, 2034 (estimated)
Last update
Feb 17, 2026

Study contacts

Christine Baldus, MH
Contact
baldusc@wustl.edu
6184444130
Ray Pinteric
Contact
ray.pinteric@outlook.com
Shay Bess, MD
principal investigator · Presbyterian/St Luke's Medical Center
Jeffrey Mullin, MD
principal investigator · University at Buffalo, Department of Neurosurgery
Christopher Shaffrey, MD
principal investigator · Duke University Medical Center, Section of Spine Surgery
Justin Smith, MD
principal investigator · University of Virginia Medical Center, Department of Neurosurgery

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion